Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Infections × monalizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 4 Neoplasms 3 Lung Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Leukemia, Myeloid, Acute 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Infections 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 COVID-19 1 Breast Neoplasms 1 Anemia, Refractory, with Excess of Blasts 1 Adenocarcinoma Of Esophagus 1

Interventions

Trimethoprim, Sulfamethoxazole Drug Combination 7 Ciprofloxacin 6 Voriconazole 3 Vancomycin 3 Fluconazole 3 Antibiotic Prophylaxis 3 Amoxicillin-Potassium Clavulanate Combination 3 plerixafor 2 gamma-Globulins 2 Therapeutics 2 Ribavirin 2 Polymerase Chain Reaction 2 Moxifloxacin 2 Levofloxacin 2 Immunoglobulins, Intravenous 2 Granulocyte Colony-Stimulating Factor 2 Filgrastim 2 Daptomycin 2 Caspofungin 2 threonic acid 1 telavancin 1 telaprevir 1 soybean oil, phospholipid emulsion 1 peginterferon alfa-2a 1 monalizumab 1 liposomal amphotericin B 1 lime 1 human papillomavirus vaccine, L1 type 16, 18 1 fluorescein isothiocyanate-keyhole limpet hemocyanin 1 fludarabine phosphate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04333914 2022-09-30

IMMUNONCOVID

Centre Leon Berard

Phase 2 Completed

COVID-19, Infections, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡